Skip to main content
logo
AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,460.00
-160.00 (-2.42%)
Sep 4, 2026, 3:30 PM KST

AptaBio Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
181,483251,341171,234201,805237,483
Market Cap Growth
-13.00%46.78%-15.15%-15.02%-
Enterprise Value
170,671240,559146,945152,862-
Last Close Price
6460.009350.006370.009050.0010650.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Forward PE
-78.1078.1078.1078.10
PS Ratio
38.1867.9750.95623.114911.46
PB Ratio
4.305.333.163.294.54
P/TBV Ratio
4.415.453.163.324.54

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
35.9165.0543.72471.99-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.120.090.140.230.01
Net Debt / Equity Ratio
-0.26-0.27-0.44-0.63-0.32
Net Debt / EBITDA Ratio
0.590.851.192.381.85
Net Debt / FCF Ratio
0.620.831.942.522.11
Asset Turnover
0.080.050.040.00-
Inventory Turnover
4.425.75---
Quick Ratio
1.871.841.6765.1016.58
Current Ratio
2.542.611.7970.2719.63
Return on Equity (ROE)
-33.15%-32.25%-50.84%-21.21%-
Return on Assets (ROA)
-18.89%-14.13%-15.24%-14.22%-
Return on Capital Employed (ROCE)
-41.20%-30.90%-35.80%-18.40%-17.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-8.19%-6.50%-17.16%-5.98%-4.45%
FCF Yield
-9.59%-6.10%-7.24%-7.65%-3.32%
Buyback Yield / Dilution
-11.67%-14.31%-5.57%-0.05%-